Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.

Bioactive molecules only contain a relatively limited number of unique ring types. To identify those ring properties and structural characteristics that are necessary for biological activity, a large virtual library of nearly 600 000 heteroaromatic scaffolds was created and characterized by calculated properties, including structural features, bioavailability descriptors, and quantum chemical parameters. A self-organizing neural network was used to cluster these scaffolds and to identify properties that best characterize bioactive ring systems. The analysis shows that bioactivity is very sparsely distributed within the scaffold property and structural space, forming only several relatively small, well-defined "bioactivity islands". Various possible applications of a large database of rings with calculated properties and bioactivity scores in the drug design and discovery process are discussed, including virtual screening, support for the design of combinatorial libraries, bioisosteric design, and scaffold hopping.

[1]  R. McGuire,et al.  Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments. , 1996, Journal of medicinal chemistry.

[2]  William L. Jorgensen,et al.  Computer-assisted mechanistic evaluation of organic reactions. 2. Perception of rings, aromaticity, and tautomers , 1981, J. Chem. Inf. Comput. Sci..

[3]  Peter Willett,et al.  Scaffold Searching: Automated Identification of Similar Ring Systems for the Design of Combinatorial Libraries , 2002 .

[4]  Peter Ertl,et al.  Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..

[5]  Herbert Waldmann,et al.  Natural product guided compound library development. , 2002, Current medicinal chemistry.

[6]  J. Drews.  In Quest of Tomorrow's Medicines , 1999 .

[7]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Paul M. Selzer,et al.  Web-based cheminformatics tools deployed via corporate Intranets , 2004 .

[9]  M. Stahl,et al.  Scaffold hopping. , 2004, Drug discovery today. Technologies.

[10]  M. Karelson,et al.  Quantum-Chemical Descriptors in QSAR/QSPR Studies. , 1996, Chemical reviews.

[11]  Gavin Harper,et al.  Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. , 2003, Journal of medicinal chemistry.

[12]  P. Selzer,et al.  Identification and Classification of GPCR Ligands Using Self‐Organizing Neural Networks , 2005 .

[13]  Alan H. Lipkus,et al.  Exploring Chemical Rings in a Simple Topological-Descriptor Space , 2001, J. Chem. Inf. Comput. Sci..

[14]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[15]  Ian A. Watson,et al.  Selection of heterocycles for drug design. , 2004, Journal of molecular graphics & modelling.

[16]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[17]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[18]  Andrew I Su,et al.  HierS: hierarchical scaffold clustering using topological chemical graphs. , 2005, Journal of medicinal chemistry.

[19]  Michael F. Lynch,et al.  Review of ring perception algorithms for chemical graphs , 1989, J. Chem. Inf. Comput. Sci..

[20]  Johann Gasteiger,et al.  Neural networks in chemistry and drug design , 1999 .